Cornerstone Capital Management Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$885K	Buy	19,098 +2,000	+12%	+$98.1K	0.01%	921
2017 Q3	$909K	Sell	17,098 -1,100	-6%	-$65.2K	0.01%	947
2017 Q2	$1.13M	Buy	18,198 +2,044	+13%	+$123K	0.01%	879
2017 Q1	$1.09M	Buy	16,154 +8,237	+104%	+$628K	0.01%	908
2016 Q4	$556K	Sell	7,917 -300	-4%	-$21.3K	﹤0.01%	1069
2016 Q3	$582K	Buy	8,217 +3,786	+85%	+$242K	﹤0.01%	1048
2016 Q2	$216K	Hold	4,431	–	–	﹤0.01%	1190
2016 Q1	$281K	Sell	4,431 -1,000	-18%	-$65.4K	﹤0.01%	1151
2015 Q4	$609K	Buy	5,431 +31	+0.6%	+$3.1K	0.01%	998
2015 Q3	$520K	Buy	5,400 +1,000	+23%	+$114K	﹤0.01%	1001
2015 Q2	$451K	Buy	+4,400	New	+$342K	﹤0.01%	1032

Other funds holding RARE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cornerstone Capital Management Holdings's RARE Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Ultragenyx Pharmaceutical (RARE) stake by 12% in Q4 2017, buying an estimated $98.1K and bringing the position to 19,098 shares worth $885K. The position accounts for 0.01% of the portfolio, ranked #921.

Cornerstone Capital Management Holdings first reported a position in RARE in Q2 2015 and has held it in 11 quarters since. The position peaked at $1.13M in Q2 2017. 163 funds tracked by Wall St. Rank hold RARE as of Q4 2017.

Cornerstone Capital Management Holdings held 19,098 shares of Ultragenyx Pharmaceutical worth $885K as of Q4 2017.
Cornerstone Capital Management Holdings bought 2,000 Ultragenyx Pharmaceutical shares in Q4 2017, an estimated $98.1K.
Ultragenyx Pharmaceutical made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #921 holding.
Cornerstone Capital Management Holdings first reported a position in Ultragenyx Pharmaceutical in Q2 2015 and has held it in 11 quarters since.
Cornerstone Capital Management Holdings's Ultragenyx Pharmaceutical position peaked at $1.13M in Q2 2017.
163 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.